1. Home
  2. KBSX vs ACRV Comparison

KBSX vs ACRV Comparison

Compare KBSX & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FST Corp. Ordinary Shares

KBSX

FST Corp. Ordinary Shares

HOLD

Current Price

$1.15

Market Cap

51.0M

ML Signal

HOLD

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$1.62

Market Cap

56.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBSX
ACRV
Founded
1976
2018
Country
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
56.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KBSX
ACRV
Price
$1.15
$1.62
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$13.00
AVG Volume (30 Days)
12.4K
839.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$805.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$1.05
52 Week High
$8.75
$6.08

Technical Indicators

Market Signals
Indicator
KBSX
ACRV
Relative Strength Index (RSI) 36.99 39.07
Support Level $1.16 $1.46
Resistance Level $1.27 $1.71
Average True Range (ATR) 0.04 0.12
MACD 0.00 -0.00
Stochastic Oscillator 29.41 26.36

Price Performance

Historical Comparison
KBSX
ACRV

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

Share on Social Networks: